Inventor
GALE ROBERT M
US71 patents
⚠️ This page may combine multiple inventors who share the name “GALE ROBERT M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALZA CORP
46 patentsUS5242391ASep 7, 1993
Urethral insert for treatment of erectile dysfunction
ALZA CORP142 citations99
US4904475AFeb 27, 1990
Transdermal delivery of drugs from an aqueous reservoir
ALZA CORP148 citations99
US4816258AMar 28, 1989
Transdermal contraceptive formulations
ALZA CORP188 citations99
US4645502AFeb 24, 1987
Transdermal delivery of highly ionized fat insoluble drugs
ALZA CORP189 citations99
US4559222ADec 17, 1985
Matrix composition for transdermal therapeutic system
ALZA CORP238 citations99
US4478818AOct 23, 1984
Ocular preparation housing steroid in two different therapeutic forms
ALZA CORP186 citations99
US4304765ADec 8, 1981
Ocular insert housing steroid in two different therapeutic forms
ALZA CORP220 citations99
US4281654AAug 4, 1981
Drug delivery system for controlled ocular therapy
ALZA CORP178 citations99
US6375978B1Apr 23, 2002
Rate controlling membranes for controlled drug delivery devices
ALZA CORP307 citations98
US5635203AJun 3, 1997
Transdermal device having decreased delamination
ALZA CORP113 citations98
US5004610AApr 2, 1991
Subsaturated nicotine transdermal therapeutic system
ALZA CORP166 citations98
US4849226AJul 18, 1989
Method for increasing oxygen supply by administering vasodilator
ALZA CORP140 citations98
US4588580AMay 13, 1986
Transdermal administration of fentanyl and device therefor
ALZA CORP641 citations98
US6512010B1Jan 28, 2003
Formulations for the administration of fluoxetine
ALZA CORP76 citations97
US5314694AMay 24, 1994
Transdermal formulations, methods and devices
ALZA CORP127 citations97
US4788062ANov 29, 1988
Transdermal administration of progesterone, estradiol esters, and mixtures thereof
ALZA CORP231 citations97
US6165497ADec 26, 2000
Subsaturated nicotine transdermal therapeutic system
ALZA CORP58 citations96
US5900250AMay 4, 1999
Monoglyceride/lactate ester permeation enhancer for oxybutnin
ALZA CORP54 citations96
US5843468ADec 1, 1998
Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
ALZA CORP158 citations96
US5840327ANov 24, 1998
Transdermal drug delivery device having enhanced adhesion
ALZA CORP78 citations96
US5614211AMar 25, 1997
Oxybutynin transdermal device having decreased delamination
ALZA CORP50 citations96
US5443461AAug 22, 1995
Segmented device for simultaneous delivery of multiple beneficial agents
ALZA CORP140 citations96
US5376377ADec 27, 1994
Transdermal contraceptive formulations, methods and devices
ALZA CORP57 citations96
US5364630ANov 15, 1994
Subsaturated nicotine transdermal therapeutic system
ALZA CORP87 citations96
US5284660AFeb 8, 1994
Delayed onset transdermal delivery device
ALZA CORP100 citations96
US5122382AJun 16, 1992
Transdermal contraceptive formulations, methods and devices
ALZA CORP79 citations96
US4834979AMay 30, 1989
Medical bandage for administering beneficial drug
ALZA CORP57 citations96
US4725272AFeb 16, 1988
Novel bandage for administering beneficial drug
ALZA CORP116 citations96
US4661105AApr 28, 1987
Medical bandage for administering vasodilator drug
ALZA CORP55 citations96
US4615699AOct 7, 1986
Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
ALZA CORP134 citations96
US4432964AFeb 21, 1984
Topical composition containing steroid in two forms released independently from polymeric carrier
ALZA CORP72 citations96
US4303637ADec 1, 1981
Medication indicated for ocular hypertension
ALZA CORP112 citations96
US6660295B2Dec 9, 2003
Transdermal drug delivery device package with improved drug stability
ALZA CORP70 citations95
US4940586AJul 10, 1990
Skin permeation enhancer compositions using sucrose esters
ALZA CORP65 citations95
US4865848ASep 12, 1989
Skin permeation enhancer compositions using sucrose esters
ALZA CORP109 citations95
US4704119ANov 3, 1987
Method comprising transdermal and buccal treatment of angina
ALZA CORP67 citations95
US4832953AMay 23, 1989
Method for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrix
ALZA CORP100 citations94
US4698062AOct 6, 1987
Medical device for pulsatile transdermal delivery of biologically active agents
ALZA CORP136 citations93
US7011844B2Mar 14, 2006
Formulations for the administration of fluoxetine
ALZA CORP29 citations92
US5512292AApr 30, 1996
Transdermal contraceptive formulations methods and devices
ALZA CORP50 citations92
US5198223AMar 30, 1993
Transdermal formulations, methods and devices
ALZA CORP46 citations92
US4900555AFeb 13, 1990
Skin permeation enhancer compositions using sucrose esters
ALZA CORP51 citations92
US4681584AJul 21, 1987
Transdermal delivery system for delivering nitroglycerin at high transdermal fluxes
ALZA CORP47 citations92
US4650484AMar 17, 1987
Method for treating ischemic conditions
ALZA CORP39 citations92
US4486193ADec 4, 1984
Method for treating ischemic conditions by administering drug by two routes
ALZA CORP43 citations92
US4190642AFeb 26, 1980
Ocular therapeutic system for dispensing a medication formulation
ALZA CORP134 citations92
VIVUS INC
2 patents(unassigned)
2 patentsShowing the top 50 of 71 patents by PatentIndex Score.